Prosecution Insights
Last updated: November 18, 2026

Sigmund Lindner GmbH

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Sigmund Lindner GmbH has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, JUSTICE, GINA CHIEUN YU, who is the busiest examiner for the portfolio with 1 busiest examiner pending action.

The prosecution is limited to 1 distinct art unit, showing a very narrow technical focus at this stage. For a practitioner, the primary task is to adapt to the specific examination style of JUSTICE, GINA CHIEUN YU. The fact that 1 distinct examiner is responsible for the entire pending workload means that the company's success in this technology area is currently tied to a single relationship.

With 1 distinct art unit involved, the practitioner does not need to manage the differing procedural expectations of multiple USPTO divisions. This streamlined profile allows for a highly targeted response to the 1 pending office action. However, the lack of examiner diversity means the portfolio does not have the benefit of spreading risk across different individuals.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JUSTICE, GINA CHIEUN YU 1 55.6% +8.4%

Top Art Units

Art UnitApps
1617 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18788198 GLITTER AND ITS USE IN COSMETIC FORMULATIONS, COATING MATERIALS AND PLASTICS JUSTICE, GINA CHIEUN YU 1617 §112Other Non-Final OA — Pending Jul 30, 2024

Managing Sigmund Lindner GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Sigmund Lindner GmbH have?

Sigmund Lindner GmbH has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Sigmund Lindner GmbH applications?

Gina Chieun Yu Justice has the most, with 1 of Sigmund Lindner GmbH's pending office actions.

What technology area are Sigmund Lindner GmbH's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month